KURVARG HEALTHCARE LTD

Executive Summary

Kurvarg Healthcare Ltd is an active micro-entity with a positive net asset position and no compliance issues as of its first financial year. However, its very recent incorporation, small scale, and director concentration require cautious monitoring of operational viability and governance. Overall, current data supports a low-risk rating but further due diligence on trading performance and liquidity is recommended.

KURVARG HEALTHCARE LTD - Analysis Report

Company Number: 15392476

Analysis Date: 2025-07-20 14:11 UTC

1. Risk Rating: LOW
   Kurvarg Healthcare Ltd is a newly incorporated micro-entity with modest net assets and no overdue filings. Its financial position shows positive net current assets and shareholders’ funds, indicating initial solvency and compliance with filing requirements.

2. Key Concerns:

• Limited operational history (incorporated January 2024) restricts the ability to assess long-term sustainability or cash flow trends.
• Very small scale of operations with only one employee and low asset base may expose the company to operational risks and lack of diversification.
• Single director and sole shareholder concentration pose governance risks and potential dependency on one individual’s capacity and decision-making.

3. Positive Indicators:

• Current assets exceed current liabilities, providing a positive working capital position as at the latest accounts date.
• No overdue accounts or confirmation statement filings indicate sound regulatory compliance to date.
• Director has relevant professional occupation (locum pharmacist) aligned with the company’s industry (dispensing chemist), suggesting domain expertise.

4. Due Diligence Notes:

• Review cash flow projections and initial trading performance to assess liquidity beyond the opening balance sheet snapshot.
• Confirm absence of liabilities or contingent risks outside of reported figures, including any related party transactions with the sole director.
• Monitor ongoing compliance with filing deadlines and any changes in shareholding or directorship that could affect control or governance.